Glenmark Pharmaceuticals' subsidiary has received approval from China's National Medical Products Administration for RYALTRIS nasal spray, designed to treat allergic rhinitis. This approval marks a ...
Inspire Pharmaceuticals is saying a recent trial of its treatment for perennial allergic rhinitis was well-tolerated but it missed its primary endpoint of "significantly reducing the total nasal ...
An update of recommendations for the treatment of seasonal allergic rhinitis (SAR) in adolescents and adults, issued by members of the Joint Task Force on Practice Parameters (JTFPP), changes initial ...
RYALTRIS is a first-of-its-kind fixed-dose combination nasal spray that brings together an olopatadine hydrochloride ...
Treatment of seasonal allergic rhinitis in patients ≥6 years old and perennial allergic rhinitis in patients ≥12 years old. Omnaris is an alcohol-free, hypotonic suspension formulation of the ...
Glenmark's subsidiary receives China approval for Ryaltris nasal spray, enhancing treatment options for allergic rhinitis in ...
For patients with allergic rhinitis whose symptoms aren't helped by one treatment, adding another may work, according to results of a systematic review and meta-analysis published in a recent issue of ...
Oral second-generation antihistamines are considered first-line therapy for allergic rhinitis but are not indicated for nonallergic vasomotor rhinitis. 1 Intranasal antihistamines can also be ...
There is a link between alcohol consumption and increased risk of perennial allergic rhinitis, according to a recent Danish study of 5,870 young adult women. The study, published in the July issue of ...
Jane Mwikali is experiencing a runny and blocked nose resulting in difficulty breathing. This is partly caused by the current and ever changing weather pattern caused by unpredictable climate change.
Glenmark has received approval from China's NMPA for its Ryaltris nasal spray for allergic rhinitis, strengthening its ...
Glenmark Pharmaceuticals Ltd on Monday said its arm Glenmark Specialty SA has received approval from China's National Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results